Print Page | Sign In | Join
Business Wire Life Sciences News (US)
Share |

Stimwave Launches Post-Market Peripheral Neuropathy Pain Relief Randomized Controlled Trial for Pain Awareness MonthOpen in a New Window

POMPANO BEACH, Fla.--(BUSINESS WIRE)--Stimwave Technologies, the leading innovator of wireless medical device bioelectronic technology, in honor of September Pain Awareness Month, today announces the launch of a new randomized clinical trial treating painful peripheral neuropathy, the “SMOOTH” study. Painful peripheral neuropathy resulting from damage to the peripheral nervous system affects an estimated 20 million people in the United States alone according the CDC. Nerve stimulation is a well

 

CORRECTING and REPLACING Three Hospital Systems Earn Five-Star Award from Patient Safety Movement FoundationOpen in a New Window

IRVINE, Calif.--(BUSINESS WIRE)--Dignity Health, MedStar Health and UPMC have earned 5-Star Awards for their commitments to PSMF APSS to eliminate preventable patient deaths.

 

CureDuchenne Announces 2020 Line-Up of Educational Events Across U.S. for Duchenne CommunityOpen in a New Window

NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- #cureduchenne--CureDuchenne Announces Line-Up of 2020 Educational Events for Duchenne Community

 

Invacare Corporation Appoints Julie Beck to Board of DirectorsOpen in a New Window

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) today announced the appointment of Julie Beck to its Board of Directors, effective September 18, 2019. Ms. Beck currently serves as senior vice president and chief financial officer for NOVA Chemicals Corporation, a petrochemical company, a position she has held since 2016. Ms. Beck has more than 30 years of experience in the manufacturing, industrial and consumer industries, and is a certified public accountant. Ms. Beck was unani

 

Tandem Diabetes Care Announces Publication of Real-world Basal-IQ Predictive Low Glucose Suspend Technology Data in Diabetes Technology and Therapeutics JournalOpen in a New Window

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care announces publication of real-world data from more than 8,000 users of the t:slim X2 insulin pump with Basal-IQ technology.

 

Savara to Present Comprehensive Data From Pivotal Phase 3 IMPALA Study at 2019 ERSOpen in a New Window

AUSTIN, Texas--(BUSINESS WIRE)--Savara to Present Comprehensive Data From Pivotal Phase 3 IMPALA Study at 2019 ERS

 

Agilent Technologies Announces Cash Dividend of 16.4 Cents Per ShareOpen in a New Window

SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent announces dividend

 

VBI Vaccines Announces Proposed Public Offering of Common SharesOpen in a New Window

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $VBIV--VBI Vaccines Inc. (Nasdaq: VBIV) (VBI or the Company), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced that it has commenced an underwritten public offering of its common shares. VBI also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of common shares offered in the public offering. The offering is subject to market and

 

Phase I Study Results Show First-in-class NBTXR3 Could Present as a Valuable Option for Patients With Hepatocellular Carcinoma or Liver MetastasisOpen in a New Window

PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News: NANOBIOTIX (Paris:NANO): “The patient population in this study has significant unmet needs primarily due to pre-existing issues with hepatic function. When you combine that with the fact that there is low life expectancy for this group, you have a critical need for innovative treatment solutions. These data provide promising evidence that NBTXR3 activated by SBRT could be a valuable option with excellent safety and increased efficacy,

 

CleanCision Shown to Significantly Reduce High Surgical Site Infection Rates in Colorectal Surgery as Compared to Standard Wound ProtectorsOpen in a New Window

SAN CARLOS, Calif.--(BUSINESS WIRE)--CleanCision (TM), novel irrigating wound protection therapy shown to reduce high rates of SSI by 100% as compared to a standard wound protector.

 

CORRECTING and REPLACING CDISC Publishes First Standard Using Traditional Chinese MedicineOpen in a New Window

AUSTIN, Texas--(BUSINESS WIRE)--CDISC releases first global Therapeutic Area Standard using Traditional Chinese Medicine.

 

Susan G. Komen® Strengthens Its Advocacy Efforts with Launch of New Komen Center for Public PolicyOpen in a New Window

WASHINGTON--(BUSINESS WIRE)--Susan G. Komen® today unveiled the Susan G. Komen® Center for Public Policy, which fights for the interests of those impacted by breast cancer.

 

Dr. Robert Petit Follows His Passion to OS Therapies as Chief Medical & Scientific AdvisorOpen in a New Window

WASHINGTON--(BUSINESS WIRE)--OS Therapies today announced the appointment of Robert Petit, Ph.D., as its Chief Medical and Scientific Advisor.

 

GrAI Matter Labs Reveals NeuronFlow Technology and Announces GrAIFlow SDKOpen in a New Window

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--GrAI Matter Labs (aka GML), a neuromorphic computing pioneer today revealed NeuronFlow – a new programmable processor technology - and announced an early access program to its GrAIFlow software development kit. GML’s NeuronFlow technology draws from neuromorphic and dataflow paradigms to uniquely solve core problems for real world AI applications. One of the breakthroughs of the technology is dynamic dataflow processing of real-time data, which drasticall

 

Stericycle Partners with the National Safety Council to Release the NSC Employer Toolkit Addressing Opioids in the WorkplaceOpen in a New Window

WASHINGTON, D.C.--(BUSINESS WIRE)--Stericycle is the exclusive launch partner for the new National Safety Council Employer Toolkit that employers can use to address the opioid crisis.

 

Pharmacy Times Continuing Education™ to Host Directions in Oncology Pharmacy™ Conference in OrlandoOpen in a New Window

CRANBURY, N.J.--(BUSINESS WIRE)-- #Immunotherapy--Pharmacy Times Continuing Education™ (PTCE), a leader in continuing education for retail, health-system, managed care, oncology and specialty pharmacists, will host the third of its 2019 Directions in Oncology Pharmacy™ fall conference series on Saturday, Oct. 19, at the Wyndham Grand Orlando Resort Bonnet Creek Hotel, in Orlando, Florida. This one-day pharmacy conference will provide live practical education to pharmacists in the inpatient, ambulatory, infusion

 

Onxeo Announces Positive Intermediate Results From the First Part of the DRIIV-1b Study Evaluating AsiDNA™ in Combination With ChemotherapyOpen in a New Window

PARIS--(BUSINESS WIRE)--Regulatory News: Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO - FR0010095596), (“Onxeo” or “the Company”), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage response (DDR) in oncology, in particular against rare or resistant cancers, today announced positive results from the first group of patients in the DRIIV 1b study, evaluating AsiDNA™, first-in-class inhibitor of tumor DNA repair, in combina

 

Vetter’s Chicago Site Wins Award ‘One of the Best and Brightest Companies to Work For®’Open in a New Window

SKOKIE, Illinois & RAVENSBURG, Germany--(BUSINESS WIRE)--Vetter announced that its US clinical manufacturing site located in Skokie has been named as one of Chicago’s Best and Brightest Companies to Work for

 

Scott Mushkin, Top Ranked Food Retail and Consumer Staples Analyst by Institutional Investor and Thomson Reuters, Launches R5 Capital in partnership with Analyst HubOpen in a New Window

NEW YORK--(BUSINESS WIRE)--Analyst Hub, LLC, an independent research infrastructure platform company that provides talented sell-side analysts a path to owning their own enterprises, and R5 Capital, a boutique consumer-centric equity research and consulting firm focused on utilizing proprietary data and significant “boots on the ground” analysis to identify unique investment opportunities and provide strategic advice for companies, today announced their partnership with the launch of R5 Capital

 

INTRODUCING VERTOSA: Cannabis and Hemp Infusion Technology Company Nanogen Labs Announces RebrandOpen in a New Window

OAKLAND, Calif.--(BUSINESS WIRE)-- #beverages--Nanogen, an innovative cannabis technology company for infused products, is rebranding under a new name, Vertosa, and adding five new talented hires.

 

Praesidian Capital Acquires Genetics BusinessOpen in a New Window

NEW YORK--(BUSINESS WIRE)--Praesidian Capital Acquires Genetics Business

 

Abacus Health Products to Participate in Financial Industry ConferencesOpen in a New Window

WOONSOCKET, R.I. & TORONTO--(BUSINESS WIRE)---- $ABAHF #AbacusHealthProducts--Abacus Health Products to participate in upcoming financial industry conferences to be held in Toronto and New York City.

 

 How Will IoT Revolutionize Pharmaceutical Manufacturing? Read Infiniti’s Latest Blog for More InsightsOpen in a New Window

LONDON--(BUSINESS WIRE)-- #CompetitiveIntelligence--Infiniti Research has announced the completion of their latest article on IoT in pharmaceutical manufacturing: how it will make a difference.

 

DeepIntent Achieves the Industry’s First True 1:1 Marketing Solution for Healthcare and Pharmaceutical BrandsOpen in a New Window

NEW YORK--(BUSINESS WIRE)--DeepIntent introduces MarketMatch™ for Advertisers, the first end-to-end programmatic advertising solution for healthcare and pharmaceutical brands.

 

OncLive® Presents State of the Science Summit™ on Non-Small Cell Lung CancerOpen in a New Window

CRANBURY, N.J.--(BUSINESS WIRE)-- #Cancer--OncLive®, the nation’s leading multimedia resource focused on providing oncology professionals with the most current and insightful information they need to offer the best patient care, will host its latest State of the Science Summit™ on Non-Small Cell Lung Cancer (NSCLC) on Thursday, Sept. 26, from 5-9 p.m. at the Omni William Penn Hotel, in Pittsburgh, Pennsylvania. The chair for the summit will be Antoinette Wozniak, M.D., FACP, FASCO, medical oncologist, as

 

bluebird bio Presents Updated Data from Phase 2/3 Clinical Study of Lenti-D™ Gene Therapy for Cerebral Adrenoleukodystrophy (CALD) at the 13th European Pediatric Neurology Society (EPNS) CongressOpen in a New Window

CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio presents updated data from Phase 2/3 clinical study of Lenti-D Gene Therapy for CALD at the 13th Annual EPNS Congress.

 

Rocky Mountain Institute CEO Jules Kortenhorst Joins Solidia Technologies Board of DirectorsOpen in a New Window

PISCATAWAY, N.J.--(BUSINESS WIRE)-- #CO2--Rocky Mountain Inst. CEO Jules Kortenhorst joins Board of Solidia whose tech reduces footprint of cement & concrete 70%, at least 1.5 GT CO2 each yr.

 

Worldwide Clinical Trials Hires Aman Khera to Lead Global Regulatory StrategyOpen in a New Window

MORRISVILLE, N.C.--(BUSINESS WIRE)--Worldwide Clinical Trials announces that Aman Khera joined the company’s Scientific Solutions team as global head of regulatory strategy.

 

Compulink Launches E-Commerce Solution for its All-in-One Optometry EHR at Vision Expo WestOpen in a New Window

NEWBURY PARK, Calif.--(BUSINESS WIRE)--Compulink launches e-commerce solution for its all-in-one Optometry EHR at Vision Expo West.

 

Apollo Endosurgery Receives 510(k) Clearance for Polypropylene Suture-Anchor AssemblyOpen in a New Window

AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery Receives 510(k) Clearance for Polypropylene Suture-Anchor Assembly

 

TherOx Announces Key SuperSaturated Oxygen Therapy Presentations at TCT 2019Open in a New Window

IRVINE, Calif.--(BUSINESS WIRE)-- #TCT2019--TherOx announces key data presentations and company-sponsored events for SuperSaturated Oxygen (SSO2) Therapy at the upcoming TCT 2019 meeting.

 

Biodesix Announces New Clinical Data Demonstrating VeriStrat Testing Predicts Survival in Advanced NSCLC and ImmunotherapyOpen in a New Window

BOULDER, Colo.--(BUSINESS WIRE)--Positive results from multiple studies support clinical utility of VeriStrat testing in advanced NSCLC and immunotherapy.

 

PIH Health Joins Alignment Healthcare Network in Southern CaliforniaOpen in a New Window

ORANGE, Calif.--(BUSINESS WIRE)--Alignment Healthcare, a Medicare Advantage insurance provider, announced today that it has added PIH Health, a nonprofit health care system that serves 2.5 million residents in Los Angeles and Orange counties, to its provider network. “PIH Health has been a cornerstone in Southeastern Los Angeles County and Northern Orange County, providing some of the most advanced care available anywhere to keep our communities healthy,” said James R. West, PIH Health presiden

 

Aural Analytics, Inc. Selected to Chair Voice Session at the 10th Annual CNS SummitOpen in a New Window

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- #AI--Aural Analytics selected to chair Voice Session at the 10th Annual CNS Summit, which will focus on the use of vocal biomarkers in clinical trials.

 

Velan Launches Consent Solicitation to Reconstitute the Progenics Board With Its Five Highly-Qualified, Independent Director NomineesOpen in a New Window

ALPHARETTA, Ga.--(BUSINESS WIRE)--Velan Capital, L.P. (together with the other members of its group, “Velan” or “we”), one of the largest stockholders of Progenics Pharmaceuticals, Inc. (“Progenics” or the “Company”)(NASDAQ:PGNX), comprised of successful specialty pharmaceutical operators and financial services experts, today announced that it has filed a preliminary consent statement with the SEC and delivered a written consent to the Company seeking to reconstitute the Progenics Board of Dire

 

Prilenia’s Pridopidine Chosen to Participate in the First ALS Platform TrialOpen in a New Window

HERZLIYA, Israel & BOSTON--(BUSINESS WIRE)--Prilenia’s Pridopidine Chosen to Participate in the First ALS Platform Trial by Led by the Sean M. Healey & AMG Center for ALS at Mass General

 

Graybug Vision Initiates Clinical Trial in Macular Edema Secondary to Diabetic Macular Edema or Retinal Vein OcclusionOpen in a New Window

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Graybug Vision Initiates Clinical Trial in Macular Edema Secondary to Diabetic Macular Edema or Retinal Vein Occlusion

 

MEDIA ALERT: NorthStar Medical Radioisotopes to Host Groundbreaking and Speaker Event Featuring Representatives from U.S. Department of Energy’s National Nuclear Security Administration, State of Wisconsin and Industry ExpertsOpen in a New Window

--(BUSINESS WIRE)--NorthStar Medical Radioisotopes to Host Ribbon-cutting, Groundbreaking and Speaker Event on Sept. 19, 2019 in Beloit, Wis.

 

United States Asthma Spacers Market Analysis, 2019-2024: Demand & Supply, Key Influencers, Opportunities & Trends, Leading Companies - ResearchAndMarkets.comOpen in a New Window

DUBLIN--(BUSINESS WIRE)--The "United States Asthma Spacers Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering. The country research report on United States asthma spacers market is a customer intelligence and competitive study of the United States market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the United States market. Also, factors that

 

X4 Pharmaceuticals Appoints Renato Skerlj, Ph.D. as Senior Vice President of Research and DevelopmentOpen in a New Window

CAMBRIDGE, Mass.--(BUSINESS WIRE)--X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced the appointment of Renato Skerlj, Ph.D., as Senior Vice President, Research and Development. Dr. Skerlj has twenty-five years of experience leading the discovery and development of small molecule drugs to treat rare diseases, cancer, infection and neurodegenerative diseases. In

 

Anika Commences U.S. Commercial Launch of TACTOSET Bone Repair Therapy Under Its New U.S. Hybrid Commercial ModelOpen in a New Window

BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company leveraging its proprietary hyaluronic acid ("HA") technology platform to provide therapies across the Joint Preservation and Restoration continuum of care, today announced it has commenced the U.S. commercial soft launch of TACTOSET, its injectable HA-enhanced bone repair therapy. TACTOSET has been developed for the treatment of bone voids and other bone defects of the ske

 

insitro Announces Key Leadership AppointmentsOpen in a New Window

SOUTH SAN FRANCISCO--(BUSINESS WIRE)--insitro, a machine-learning driven drug discovery and development company, today announced key appointments to the company’s leadership team. Matthew Rasmussen, Ph.D. has been appointed as vice president of data engineering, and Duane Valz, J.D. has joined as general counsel. “At insitro, we are working to advance better therapies via predictive models, enabled by the convergence of cutting-edge machine learning and data generation at scale,” said Daphne Ko

 

CoreLink Introduces Oro Lateral Plate System Designed for Optimum Versatility to Treat Patients Suffering From Spinal ConditionsOpen in a New Window

ST. LOUIS--(BUSINESS WIRE)-- #3dprinting--CoreLink introduces low-profile solution for lateral lumbar plating, featuring the ability to optionally connect to CoreLink lateral interbodies.

 

Henry Schein’s Practice Pink Program Supports the Global Fight Against CancerOpen in a New Window

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein's Practice Pink program has raised more than $1.6M for cancer research, prevention, and awareness efforts.

 

Genprex to Present Via Webcast at the Singular Research Midwestern Values Conference on September 19, 2019Open in a New Window

AUSTIN, Texas & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genprex's Chairman and CEO, Rodney Varner, will lead the company's webcast presentation on September 19, 2019.

 

IQVIA Collaborates with Cancer Researchers to Advance Use of Real World EvidenceOpen in a New Window

DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE:IQV) is proud to announce its collaboration with Friends of Cancer Research in a cross-industry effort to advance acceptance and drive future uses of real world evidence (RWE). This research helps confirm that clinical benefits seen for therapies in clinical trials were consistent with the benefits of those treatments within real world settings. RWE comprises dynamic data including assets such as EMR, hospital, pharmac

 

Martha A. Brumfield, PhD, Named Arizona Bioscience Leader of the YearOpen in a New Window

CHANDLER, Ariz.--(BUSINESS WIRE)-- #AZBW--Martha A. Brumfield, PhD, of the Critical Path Institute, will be honored as the Arizona Bioscience Leader of the Year at the 2019 AZBio Awards.

 

Progenity Acquires Medimetrics Assets and Strengthens Global Leadership Position for Ingestible Device TechnologiesOpen in a New Window

SAN DIEGO--(BUSINESS WIRE)--Progenity, Inc., a privately held biotechnology company, has acquired assets of ingestible device company Medimetrics GmbH. This acquisition further strengthens Progenity’s existing intellectual property portfolio and positions the company at the forefront of developing ingestible devices designed to advance research, diagnosis, and treatment for conditions of the gastrointestinal (GI) tract. “With the acquisition of Medimetrics’ assets, Progenity now holds one of th

 

PolarityTE to Attend the 2019 Cantor Global Healthcare ConferenceOpen in a New Window

SALT LAKE CITY--(BUSINESS WIRE)--PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that it will present at the 2019 Cantor Global Healthcare Conference on Wednesday, October 2, 2019 in New York, NY. A live audio webcast of the 2019 Cantor Global Healthcare Conference presentation on October 2, 2019 at 3:00pm ET will be accessible in real time on the "News/Events" section of PolarityTE's Investor

 

Cigna Health Care Exchange Plans Now Available in 19 Markets Across 10 StatesOpen in a New Window

BLOOMFIELD, Conn.--(BUSINESS WIRE)--Global health service company Cigna is expanding its individual health care exchange offerings to new geographies for 2020, with health plans now available in 19 markets across 10 states. This includes expansion into select counties in Kansas, South Florida and Utah as well as new counties in Tennessee and Virginia. Cigna's plans on the individual health care exchanges will include a number of features that provide access to quality health care and encourage

 

Signet Medical Solutions, Inc. (a Subsidiary of Signet International Holdings, Inc. OTC: SIGN) Announces Option to Acquire Rights of Method to Detect Melanoma Cancer by SmellOpen in a New Window

CLERMONT, Fla.--(BUSINESS WIRE)--Tom Donaldson, President, announced that Signet executed an Option to license all rights to medical non-invasive system to detect melanoma skin cancer using a vapor analysis system. The breakthrough operates in real time eliminating the time delay in diagnosis. The recently filed patent is also globally protected (PCT). “It’s exciting to avail this technology to the medical industry. It will be profitable to Signet shareholders. As a sufferer of this disease, I

 

Kraig Biocraft Laboratories Announces First New Member of Expanded Board of DirectorsOpen in a New Window

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $KBLB #KBLB--Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that it has selected Mr. Anurag Gupta for its expanded Board of Directors. Among the many significant accomplishments during his career, Mr. Gupta has served as: the CEO of Global Data Services for TBG, the President for Europe, Middle East, and Africa region for BrightPoint, Inc, and the Executive Vice President of the CMS Division a

 

Ra Pharmaceuticals Announces Selection for the First ALS Platform Trial by the Sean M. Healey & AMG Center for ALS at Mass GeneralOpen in a New Window

BOSTON & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced the selection of zilucoplan as one of the first clinical candidates to be evaluated in a pioneering platform trial for amyotrophic lateral sclerosis (ALS), led by the Sean M. Healey & AMG Center for ALS at Mass General. The Healey Center has agreed to provide funding for the execution of the platform trial to support its goal of accelerating the development of effective treatments for patients

 

Kinston Community Health Center Used NextGen Healthcare Solution to Prepare Patients Ahead of Hurricane Dorian’s LandfallOpen in a New Window

IRVINE, Calif.--(BUSINESS WIRE)-- #Believeinbetter--Kinston Community Health Center Used NextGen Healthcare's NextGen Care Solution to prepare patients ahead of Hurricane Dorian's Landfall.

 

Acorda to Present Data at the International Congress of Parkinson’s Disease and Movement DisordersOpen in a New Window

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it will present data at the International Congress of Parkinson’s Disease and Movement Disorders, taking place September 22-26, 2019 in Nice, France. The data include two posters, which will be presented on Tuesday, September 24, 2019 from 1:45 PM to 3:15 PM CEST: Dyskinesia Rates in Patients with Parkinson’s Disease on CVT-301 (levodopa inhalation powder)(Abstract #1035) Impact of OFF periods on aspec

 

Poxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of DiabetesOpen in a New Window

LYON, France--(BUSINESS WIRE)--POXEL S.A. (Euronext – POXEL – FR0012432516), a biopharmaceutical company dedicated to the development of innovative treatments for metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH), announced today the presentation of detailed Phase 3 results from the TIMES 1 program, which evaluated the efficacy, safety and tolerability of Imeglimin in Japanese patients with type 2 diabetes as well as data supporting the safety and efficacy

 

Saranas Launches Early Bird® Bleed Monitoring System in the U.S.Open in a New Window

HOUSTON--(BUSINESS WIRE)-- #EarlyBird--Saranas launches Early Bird, the first and only device for real-time detection and monitoring of endovascular bleed complications.

 

United States Wearable Injectors Market Forecast Report, 2019 to 2024 - ResearchAndMarkets.comOpen in a New Window

DUBLIN--(BUSINESS WIRE)--The "United States Wearable Injectors Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering. The country research report on the United States wearable injectors market is a customer intelligence and competitive study of the United States market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the United States market. Also,

 

Corindus to Showcase CorPath® GRX System at Transcatheter Cardiovascular Therapeutics 2019 ConferenceOpen in a New Window

WALTHAM, Mass.,--(BUSINESS WIRE)--CVRS to host breakfast symposium and hands-on demos at TCT 2019 to highlight remote and automated capabilities of its CorPath GRX technology.

 

United States Endoscopy Ultrasound Market, 2019: Prospects, Trends Analysis, Size & Forecasts to 2024 - ResearchAndMarkets.comOpen in a New Window

DUBLIN--(BUSINESS WIRE)--The "United States Endoscopy Ultrasound Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering. The country research report on United States endoscopy ultrasound market is a customer intelligence and competitive study of the United States market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the United States market. Also,

 

Freudenberg Medical Presents Two New Catheter Handle Platforms and Hemostasis Valve at TCT 2019Open in a New Window

JEFFERSONVILLE, Ind.--(BUSINESS WIRE)-- #HemostasisValve--Next generation design options for medical device companies looking to accelerate time to market. On display next week at TCT 2019 conference.

 

Biedermann Motech to Introduce MOSS VRS® - The Next Generation Pedicle Screw Technology™ to the US MarketOpen in a New Window

MIAMI & DONAUESCHINGEN, Germany--(BUSINESS WIRE)-- #FirstAndOnly--Biedermann Motech to introduce MOSS VRS® - The Next Generation Pedicle Screw Technology™ to the US market at NASS 2019 in Chicago.

 

Ironwood Pharmaceuticals and AstraZeneca Amend LINZESS® (linaclotide) Collaboration in ChinaOpen in a New Window

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI healthcare company, announced today that it has amended its collaboration agreement with AstraZeneca for the development and commercialization of LINZESS in China. LINZESS was approved by the National Medical Products Administration for adults with IBS-C in China in January 2019. LINZESS is expected to be launched in China in the second half of 2019. Under the terms of the amended agreement, AstraZeneca will

 

FDA Grants Breakthrough Therapy Designation for Genentech’s Gazyva (Obinutuzumab) in Lupus NephritisOpen in a New Window

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to Gazyva® (obinutuzumab) for adults with lupus nephritis. This designation was granted based on data from the Phase II NOBILITY study in adult patients with proliferative lupus nephritis which showed Gazyva, in combination with standard of care (mycophenolate mofetil

 

ACADIA Pharmaceuticals Prices Public Offering of Common StockOpen in a New Window

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (CNS) disorders, today announced the pricing of an underwritten public offering of 6,250,000 shares of its common stock, offered at a price to the public of $40.00 per share. The gross proceeds from this offering to ACADIA are expected to be approximately $250 million,

 

Shiseido Marks the 30th Anniversary of Joint Research in DermatologyOpen in a New Window

TOKYO--(BUSINESS WIRE)--Shiseido has agreed on Sept. 17, 2019 to extend for a further six years its research alliance with the dermatological laboratory CBRC in Boston.

 

Pulse Biosciences Grants Equity Incentive Awards to New EmployeesOpen in a New Window

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences Grants Equity Incentive Awards to New Employees

 

Sunstone Management and City of Long Beach Host Top Innovators with SoCalBioOpen in a New Window

LONG BEACH, Calif.--(BUSINESS WIRE)--Sunstone Management and the City of Long Beach’s Economic Development Department have partnered with the Southern California Biomedical Council (SoCalBio) to kick-off its 21st Annual Conference with a CEO/Investor Reception and Dinner on September 18 at the Westin Hotel in Long Beach, CA. SoCalBio, the trade association for the bioscience and digital health industries in the Greater Los Angeles region, presents its key annual event to showcase Southern Calif

 

FDA Approves KEYTRUDA® (pembrolizumab) plus LENVIMA® (lenvatinib) Combination Treatment for Patients with Certain Types of Endometrial CarcinomaOpen in a New Window

KENILWORTH, N.J., & WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)---- $MRK #MRK--FDA Approves KEYTRUDA® (pembrolizumab) plus LENVIMA® (lenvatinib) Combination Treatment for Patients with Certain Types of Endometrial Carcinoma

 

About BioFlorida

BioFlorida represents 6,200 establishments and research organizations in the biopharmaceuticals, medical technology, healthIT and bioagriculture sectors that collectively employ 87,000 Floridians.

 

Members of the BioFlorida network include emerging and established life science companies, universities, research institutions, hospitals, medical centers, incubators, economic development agencies, investors and service providers.

 

NEW regional sponsorship opportunities available.

Connect